Related Experiment Video
Updated: Jul 27, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Evaluating the role of bias in pharmacoeconomic studies
1College of Pharmacy, University of Arizona, Tucson, USA. joish@pharmacy.arizona.edu
Abstract:
Pharmacoeconomic research is conducted to provide patients, physicians, institutional providers, health benefit plan decision makers, and government authorities with information about the economic value of pharmaceuticals. Valid and appropriate pharmacoeconomic data are vital to informed decision making. Methodological guidelines have been proposed for the conduct of pharmacoeconomic research to foster high quality and minimize bias. This article outlines the types of bias that are introduced in pharmacoeconomic studies using a traditional epidemiological approach.
Related Concept Videos
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Bias in Epidemiological Studies